

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * C21-steroid hormone metabolic process (GO:0008207) | 9.56762447 |
| 2 | * progesterone metabolic process (GO:0042448) | 9.09170406 |
| 3 | * cellular response to antibiotic (GO:0071236) | 9.02671169 |
| 4 | * cellular response to gonadotropin stimulus (GO:0071371) | 8.44238093 |
| 5 | cellular response to epinephrine stimulus (GO:0071872) | 8.09494263 |
| 6 | * hormone biosynthetic process (GO:0042446) | 7.95339259 |
| 7 | cellular response to cadmium ion (GO:0071276) | 7.76575711 |
| 8 | ketone biosynthetic process (GO:0042181) | 7.51143880 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.44176531 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 7.44176531 |
| 11 | response to epinephrine (GO:0071871) | 7.18355757 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.08167522 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 7.08167522 |
| 14 | cellular response to interferon-alpha (GO:0035457) | 6.78682219 |
| 15 | toxin metabolic process (GO:0009404) | 6.76332898 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.68559879 |
| 17 | * cellular response to toxic substance (GO:0097237) | 6.60548909 |
| 18 | cellular response to growth hormone stimulus (GO:0071378) | 6.56022195 |
| 19 | response to corticosterone (GO:0051412) | 6.50213560 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 6.40487347 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 6.15999448 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 6.10039602 |
| 23 | mating behavior (GO:0007617) | 5.98275750 |
| 24 | * androgen metabolic process (GO:0008209) | 5.90819102 |
| 25 | * response to gonadotropin (GO:0034698) | 5.89469174 |
| 26 | * response to insecticide (GO:0017085) | 5.71818011 |
| 27 | urea metabolic process (GO:0019627) | 5.71749370 |
| 28 | urea cycle (GO:0000050) | 5.71749370 |
| 29 | positive regulation of male gonad development (GO:2000020) | 5.66607374 |
| 30 | estrogen metabolic process (GO:0008210) | 5.47222962 |
| 31 | tryptophan catabolic process (GO:0006569) | 5.44665870 |
| 32 | indole-containing compound catabolic process (GO:0042436) | 5.44665870 |
| 33 | indolalkylamine catabolic process (GO:0046218) | 5.44665870 |
| 34 | bile acid biosynthetic process (GO:0006699) | 5.43511821 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 5.43181628 |
| 36 | kynurenine metabolic process (GO:0070189) | 5.37625404 |
| 37 | glyoxylate metabolic process (GO:0046487) | 5.34123407 |
| 38 | reverse cholesterol transport (GO:0043691) | 5.31966477 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 5.29801468 |
| 40 | gonadal mesoderm development (GO:0007506) | 5.26144329 |
| 41 | response to mineralocorticoid (GO:0051385) | 5.23963694 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 5.23380273 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.23041805 |
| 44 | protein carboxylation (GO:0018214) | 5.23041805 |
| 45 | tryptophan metabolic process (GO:0006568) | 5.18750752 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 5.18519901 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 5.14483939 |
| 48 | regulation of fibrinolysis (GO:0051917) | 5.13903314 |
| 49 | intracellular lipid transport (GO:0032365) | 5.08103385 |
| 50 | response to lead ion (GO:0010288) | 5.06064823 |
| 51 | response to phenylpropanoid (GO:0080184) | 5.05203808 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 5.04865646 |
| 53 | macromolecular complex remodeling (GO:0034367) | 5.04865646 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 5.04865646 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 4.99211162 |
| 56 | phospholipid efflux (GO:0033700) | 4.97608364 |
| 57 | response to leptin (GO:0044321) | 4.96981252 |
| 58 | * Leydig cell differentiation (GO:0033327) | 4.93660600 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 4.93620596 |
| 60 | cysteine metabolic process (GO:0006534) | 4.92594851 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.90684785 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.90684785 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 4.89879102 |
| 64 | bile acid metabolic process (GO:0008206) | 4.87009225 |
| 65 | tyrosine metabolic process (GO:0006570) | 4.81458095 |
| 66 | parturition (GO:0007567) | 4.77324718 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74932569 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.72409287 |
| 69 | cellular response to dexamethasone stimulus (GO:0071549) | 4.70174541 |
| 70 | triglyceride homeostasis (GO:0070328) | 4.62839467 |
| 71 | acylglycerol homeostasis (GO:0055090) | 4.62839467 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 4.62614015 |
| 73 | response to vitamin E (GO:0033197) | 4.62179867 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 4.62105678 |
| 75 | cytokine metabolic process (GO:0042107) | 4.54679838 |
| 76 | regulation of male gonad development (GO:2000018) | 4.47936007 |
| 77 | cellular ketone body metabolic process (GO:0046950) | 4.47411268 |
| 78 | cholesterol efflux (GO:0033344) | 4.46923177 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 4.42767243 |
| 80 | response to dexamethasone (GO:0071548) | 4.37518879 |
| 81 | regulation of female gonad development (GO:2000194) | 4.31495821 |
| 82 | regulation of protein activation cascade (GO:2000257) | 4.30515615 |
| 83 | homocysteine metabolic process (GO:0050667) | 4.28252461 |
| 84 | complement activation, alternative pathway (GO:0006957) | 4.24797599 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 4.23581940 |
| 86 | * benzene-containing compound metabolic process (GO:0042537) | 4.22715922 |
| 87 | negative regulation of lipase activity (GO:0060192) | 4.22476551 |
| 88 | lysine metabolic process (GO:0006553) | 4.22427681 |
| 89 | lysine catabolic process (GO:0006554) | 4.22427681 |
| 90 | drug catabolic process (GO:0042737) | 4.17275208 |
| 91 | * steroid biosynthetic process (GO:0006694) | 4.15996379 |
| 92 | vitamin D metabolic process (GO:0042359) | 4.09704951 |
| 93 | * sterol metabolic process (GO:0016125) | 4.06682191 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 4.06507769 |
| 95 | cellular glucuronidation (GO:0052695) | 4.05994255 |
| 96 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.05916635 |
| 97 | bile acid and bile salt transport (GO:0015721) | 4.04244909 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 4.03166726 |
| 99 | low-density lipoprotein particle remodeling (GO:0034374) | 4.02775680 |
| 100 | glycine metabolic process (GO:0006544) | 4.02408777 |
| 101 | aggressive behavior (GO:0002118) | 4.02327159 |
| 102 | cellular response to catecholamine stimulus (GO:0071870) | 4.00898390 |
| 103 | cellular response to monoamine stimulus (GO:0071868) | 4.00898390 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 4.00125954 |
| 105 | glutamate metabolic process (GO:0006536) | 3.95355707 |
| 106 | arginine metabolic process (GO:0006525) | 3.95214025 |
| 107 | ethanol oxidation (GO:0006069) | 3.93973452 |
| 108 | regulation of female receptivity (GO:0045924) | 3.93851943 |
| 109 | coenzyme catabolic process (GO:0009109) | 3.91058636 |
| 110 | regulation of complement activation (GO:0030449) | 3.90187887 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90151352 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.89994519 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 3.88859901 |
| 114 | serine family amino acid biosynthetic process (GO:0009070) | 3.85148327 |
| 115 | ketone body metabolic process (GO:1902224) | 3.85140443 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.84292194 |
| 117 | indolalkylamine metabolic process (GO:0006586) | 3.83499584 |
| 118 | regulation of apoptotic cell clearance (GO:2000425) | 3.82277771 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.79961047 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.79285110 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.78612117 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78210401 |
| 123 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78210401 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.77310137 |
| 125 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.76674807 |
| 126 | drug metabolic process (GO:0017144) | 3.72804272 |
| 127 | sterol homeostasis (GO:0055092) | 3.71994640 |
| 128 | cellular modified amino acid catabolic process (GO:0042219) | 3.71674948 |
| 129 | fibrinolysis (GO:0042730) | 3.71618881 |
| 130 | aldehyde catabolic process (GO:0046185) | 3.71585137 |
| 131 | cellular biogenic amine catabolic process (GO:0042402) | 3.69737231 |
| 132 | amine catabolic process (GO:0009310) | 3.69737231 |
| 133 | response to monoamine (GO:0071867) | 3.69533936 |
| 134 | response to catecholamine (GO:0071869) | 3.69533936 |
| 135 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.68130914 |
| 136 | linoleic acid metabolic process (GO:0043651) | 3.68109908 |
| 137 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68060107 |
| 138 | regulation of transmission of nerve impulse (GO:0051969) | 3.65163399 |
| 139 | organic acid catabolic process (GO:0016054) | 3.64791028 |
| 140 | carboxylic acid catabolic process (GO:0046395) | 3.64791028 |
| 141 | cofactor catabolic process (GO:0051187) | 3.62780891 |
| 142 | very long-chain fatty acid metabolic process (GO:0000038) | 3.61646722 |
| 143 | protein-lipid complex subunit organization (GO:0071825) | 3.61106277 |
| 144 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.58898239 |
| 145 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.58898239 |
| 146 | * cellular hormone metabolic process (GO:0034754) | 3.56971233 |
| 147 | uronic acid metabolic process (GO:0006063) | 3.56451681 |
| 148 | glucuronate metabolic process (GO:0019585) | 3.56451681 |
| 149 | response to water (GO:0009415) | 3.56441915 |
| 150 | response to growth hormone (GO:0060416) | 3.52496044 |
| 151 | carnitine metabolic process (GO:0009437) | 3.52103784 |
| 152 | cholesterol transport (GO:0030301) | 3.51572209 |
| 153 | sterol transport (GO:0015918) | 3.51572209 |
| 154 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 3.51270755 |
| 155 | lipoprotein metabolic process (GO:0042157) | 3.49867899 |
| 156 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49786729 |
| 157 | * cellular ketone metabolic process (GO:0042180) | 3.40249482 |
| 158 | female mating behavior (GO:0060180) | 3.38964486 |
| 159 | adhesion of symbiont to host (GO:0044406) | 3.38674148 |
| 160 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35627552 |
| 161 | cholesterol metabolic process (GO:0008203) | 3.32292826 |
| 162 | response to cadmium ion (GO:0046686) | 3.22056714 |
| 163 | steroid catabolic process (GO:0006706) | 3.20226326 |
| 164 | sulfation (GO:0051923) | 3.19468470 |
| 165 | cholesterol catabolic process (GO:0006707) | 3.18909331 |
| 166 | sterol catabolic process (GO:0016127) | 3.18909331 |
| 167 | opsonization (GO:0008228) | 3.18822256 |
| 168 | positive regulation of amino acid transport (GO:0051957) | 3.09487402 |
| 169 | regulation of cholesterol homeostasis (GO:2000188) | 3.09315007 |
| 170 | * regulation of steroid biosynthetic process (GO:0050810) | 3.09177946 |
| 171 | regulation of cholesterol storage (GO:0010885) | 3.04975555 |
| 172 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.04875381 |
| 173 | response to lipoprotein particle (GO:0055094) | 3.03620290 |
| 174 | cellular sodium ion homeostasis (GO:0006883) | 2.93916321 |
| 175 | cellular response to cAMP (GO:0071320) | 2.91524313 |
| 176 | response to interferon-alpha (GO:0035455) | 2.89979308 |
| 177 | regulation of cholesterol metabolic process (GO:0090181) | 2.88286434 |
| 178 | maintenance of protein location in nucleus (GO:0051457) | 2.83345916 |
| 179 | multi-organism reproductive behavior (GO:0044705) | 2.78491432 |
| 180 | multicellular organismal aging (GO:0010259) | 2.77134826 |
| 181 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.75203090 |
| 182 | * adrenal gland development (GO:0030325) | 2.72994096 |
| 183 | positive regulation of monooxygenase activity (GO:0032770) | 2.68743547 |
| 184 | * glucocorticoid biosynthetic process (GO:0006704) | 19.2719285 |
| 185 | C21-steroid hormone biosynthetic process (GO:0006700) | 17.4187606 |
| 186 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 15.5398658 |
| 187 | * glucocorticoid metabolic process (GO:0008211) | 15.0944804 |
| 188 | response to follicle-stimulating hormone (GO:0032354) | 12.4389096 |
| 189 | * androgen biosynthetic process (GO:0006702) | 12.4105073 |
| 190 | estrogen biosynthetic process (GO:0006703) | 12.3343731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11078183 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.87787033 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41313417 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.36295513 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.84335778 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01748153 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97686838 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66765676 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.84637207 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77788139 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.55241897 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27397666 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99076161 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.87110517 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.59573105 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.51859755 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.44086788 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.40797609 |
| 19 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5275996 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97740008 |
| 21 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.95027104 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89214593 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69046687 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68300962 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67490879 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65896266 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65882026 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60158990 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60081191 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58772945 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58697957 |
| 32 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.58327487 |
| 33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55565909 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55053547 |
| 35 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50624773 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48716383 |
| 37 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47483110 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41894173 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39448787 |
| 40 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.38584320 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38077772 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35870618 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34238995 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34053049 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33162328 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32562184 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32562184 |
| 48 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32476635 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23557491 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23535260 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22370242 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18941809 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18315691 |
| 54 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17793320 |
| 55 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15948500 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13329509 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13240072 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11144045 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10279676 |
| 60 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08480225 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08402046 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08222400 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06572983 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06163381 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05901852 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05350294 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05350294 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04519567 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02200913 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01524445 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01083540 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00265250 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99464962 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98596195 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98257322 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97406323 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96708467 |
| 78 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.95757761 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95714478 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95103244 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94715181 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94650755 |
| 83 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94471006 |
| 84 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93911429 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93798971 |
| 86 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.93760294 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92455755 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91287563 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90937435 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89958738 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89548008 |
| 92 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89327823 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87580628 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86913202 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86660766 |
| 96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86101216 |
| 97 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85514868 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85489811 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84783643 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83844023 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82718770 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81685049 |
| 103 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80270743 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80184810 |
| 105 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79777032 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79564864 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77809252 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77614388 |
| 109 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77214419 |
| 110 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.76078407 |
| 111 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73562693 |
| 112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.70519109 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69344445 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.68860319 |
| 115 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67636897 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67039765 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66670048 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66456911 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65809088 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.65274527 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63584254 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.63518859 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63309001 |
| 124 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.62345786 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62316681 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.60948640 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59435887 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.58260309 |
| 129 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.57217290 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.56452635 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55060674 |
| 132 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54521418 |
| 133 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.54304811 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53441560 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52818681 |
| 136 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.51852048 |
| 137 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.51382264 |
| 138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49899717 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.48725490 |
| 140 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.48648207 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.48405550 |
| 142 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48396883 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.47922687 |
| 144 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47588821 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47585094 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47380863 |
| 147 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47195158 |
| 148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.46746650 |
| 149 | AR_20517297_ChIP-Seq_VCAP_Human | 0.46623661 |
| 150 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.46184595 |
| 151 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.45688728 |
| 152 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45242195 |
| 153 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45212159 |
| 154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.44792722 |
| 155 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44581935 |
| 156 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44558185 |
| 157 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44078563 |
| 158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43695708 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43231610 |
| 160 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.43108657 |
| 161 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.43108657 |
| 162 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.42691484 |
| 163 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.42662804 |
| 164 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.41932812 |
| 165 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41849917 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.40992843 |
| 167 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.40992843 |
| 168 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.40897252 |
| 169 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.40547291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.54065716 |
| 2 | MP0002909_abnormal_adrenal_gland | 7.73150222 |
| 3 | MP0005360_urolithiasis | 7.23001541 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.03577386 |
| 5 | MP0005365_abnormal_bile_salt | 6.02082740 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.31125489 |
| 7 | MP0008004_abnormal_stomach_pH | 4.21988393 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.73454029 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.69576995 |
| 10 | MP0003252_abnormal_bile_duct | 3.61913017 |
| 11 | MP0009840_abnormal_foam_cell | 3.54580674 |
| 12 | MP0003941_abnormal_skin_development | 3.30383458 |
| 13 | MP0003122_maternal_imprinting | 3.12154642 |
| 14 | MP0005083_abnormal_biliary_tract | 2.95532096 |
| 15 | MP0003195_calcinosis | 2.86903694 |
| 16 | MP0005332_abnormal_amino_acid | 2.74893685 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.38769167 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.35435017 |
| 19 | MP0001984_abnormal_olfaction | 2.34811000 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.32662090 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.27848691 |
| 22 | MP0001765_abnormal_ion_homeostasis | 2.18811640 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.15839593 |
| 24 | MP0000609_abnormal_liver_physiology | 2.15453007 |
| 25 | MP0003315_abnormal_perineum_morphology | 2.12635224 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.12630643 |
| 27 | MP0000647_abnormal_sebaceous_gland | 1.98918982 |
| 28 | MP0003011_delayed_dark_adaptation | 1.96815105 |
| 29 | MP0000631_abnormal_neuroendocrine_gland | 1.92238327 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.76554843 |
| 31 | MP0005410_abnormal_fertilization | 1.75359104 |
| 32 | MP0005451_abnormal_body_composition | 1.74080891 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.73174159 |
| 34 | MP0001879_abnormal_lymphatic_vessel | 1.71804162 |
| 35 | MP0003868_abnormal_feces_composition | 1.62657084 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.58003206 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55794783 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.54859460 |
| 39 | MP0002269_muscular_atrophy | 1.51788959 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.50201391 |
| 41 | MP0001485_abnormal_pinna_reflex | 1.49737628 |
| 42 | MP0001764_abnormal_homeostasis | 1.48793460 |
| 43 | MP0002160_abnormal_reproductive_system | 1.46550395 |
| 44 | MP0003121_genomic_imprinting | 1.43765091 |
| 45 | MP0009697_abnormal_copulation | 1.41834810 |
| 46 | MP0005647_abnormal_sex_gland | 1.41388516 |
| 47 | MP0005670_abnormal_white_adipose | 1.22795304 |
| 48 | MP0001119_abnormal_female_reproductive | 1.20950877 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 1.18563025 |
| 50 | MP0003878_abnormal_ear_physiology | 1.18563025 |
| 51 | MP0000604_amyloidosis | 1.16894376 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.16199785 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.15726601 |
| 54 | MP0000598_abnormal_liver_morphology | 1.14988039 |
| 55 | MP0004134_abnormal_chest_morphology | 1.11434588 |
| 56 | MP0001661_extended_life_span | 1.07571692 |
| 57 | MP0002254_reproductive_system_inflammat | 1.06151481 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.05031418 |
| 59 | MP0003186_abnormal_redox_activity | 1.04686703 |
| 60 | MP0000639_abnormal_adrenal_gland | 1.02449716 |
| 61 | MP0000013_abnormal_adipose_tissue | 0.97930879 |
| 62 | MP0004085_abnormal_heartbeat | 0.97907876 |
| 63 | MP0009053_abnormal_anal_canal | 0.97632253 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 0.96790842 |
| 65 | MP0009763_increased_sensitivity_to | 0.95754326 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.92556283 |
| 67 | MP0005408_hypopigmentation | 0.89140368 |
| 68 | MP0001915_intracranial_hemorrhage | 0.87611482 |
| 69 | MP0002938_white_spotting | 0.87531863 |
| 70 | * MP0009642_abnormal_blood_homeostasis | 0.86720274 |
| 71 | MP0000751_myopathy | 0.86180460 |
| 72 | MP0009764_decreased_sensitivity_to | 0.83874365 |
| 73 | MP0004484_altered_response_of | 0.81466017 |
| 74 | MP0005595_abnormal_vascular_smooth | 0.78364243 |
| 75 | MP0002971_abnormal_brown_adipose | 0.76726997 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.74613049 |
| 77 | MP0005253_abnormal_eye_physiology | 0.74337704 |
| 78 | MP0003959_abnormal_lean_body | 0.73919053 |
| 79 | MP0008469_abnormal_protein_level | 0.73424559 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.72880242 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.72055494 |
| 82 | MP0004130_abnormal_muscle_cell | 0.71847500 |
| 83 | MP0005334_abnormal_fat_pad | 0.71816984 |
| 84 | MP0005275_abnormal_skin_tensile | 0.71679524 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.68086683 |
| 86 | MP0003329_amyloid_beta_deposits | 0.67150916 |
| 87 | MP0002127_abnormal_cardiovascular_syste | 0.65371263 |
| 88 | * MP0002557_abnormal_social/conspecific_i | 0.65125393 |
| 89 | MP0003690_abnormal_glial_cell | 0.63975153 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.63445433 |
| 91 | MP0004272_abnormal_basement_membrane | 0.63243121 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.62643309 |
| 93 | MP0002796_impaired_skin_barrier | 0.61357995 |
| 94 | MP0003279_aneurysm | 0.61260772 |
| 95 | MP0001756_abnormal_urination | 0.60955179 |
| 96 | MP0005535_abnormal_body_temperature | 0.58443688 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.58331575 |
| 98 | MP0005448_abnormal_energy_balance | 0.56712882 |
| 99 | MP0000653_abnormal_sex_gland | 0.56546758 |
| 100 | MP0005266_abnormal_metabolism | 0.56084320 |
| 101 | MP0004742_abnormal_vestibular_system | 0.55541158 |
| 102 | MP0001905_abnormal_dopamine_level | 0.55415727 |
| 103 | MP0002210_abnormal_sex_determination | 0.54838723 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.54837419 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.54356593 |
| 106 | MP0005395_other_phenotype | 0.53898288 |
| 107 | MP0001486_abnormal_startle_reflex | 0.53075286 |
| 108 | * MP0003698_abnormal_male_reproductive | 0.52642527 |
| 109 | MP0003879_abnormal_hair_cell | 0.51957458 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.51651679 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.51190840 |
| 112 | MP0003632_abnormal_nervous_system | 0.50225720 |
| 113 | MP0009672_abnormal_birth_weight | 0.49042860 |
| 114 | MP0008057_abnormal_DNA_replication | 0.48675779 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.47384719 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.47254981 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.47022346 |
| 118 | * MP0001929_abnormal_gametogenesis | 0.46882448 |
| 119 | MP0002168_other_aberrant_phenotype | 0.46339803 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.45916021 |
| 121 | MP0000343_altered_response_to | 0.45857175 |
| 122 | * MP0003953_abnormal_hormone_level | 0.45805926 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.45732312 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.45729623 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.45620813 |
| 126 | MP0008770_decreased_survivor_rate | 0.44747989 |
| 127 | MP0005164_abnormal_response_to | 0.44208889 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.43438319 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.43188177 |
| 130 | MP0001145_abnormal_male_reproductive | 0.42204796 |
| 131 | MP0001243_abnormal_dermal_layer | 0.42067196 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.41895195 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.41269954 |
| 134 | MP0002115_abnormal_skeleton_extremities | 0.40896782 |
| 135 | MP0000462_abnormal_digestive_system | 0.39811078 |
| 136 | MP0008874_decreased_physiological_sensi | 0.38703087 |
| 137 | MP0003718_maternal_effect | 0.38105282 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.37763288 |
| 139 | MP0004883_abnormal_blood_vessel | 0.37187193 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.36913346 |
| 141 | MP0002970_abnormal_white_adipose | 0.36134735 |
| 142 | MP0002282_abnormal_trachea_morphology | 0.35619365 |
| 143 | MP0005330_cardiomyopathy | 0.35243577 |
| 144 | MP0005389_reproductive_system_phenotype | 0.35005000 |
| 145 | * MP0002161_abnormal_fertility/fecundity | 0.34892359 |
| 146 | MP0009115_abnormal_fat_cell | 0.34626993 |
| 147 | MP0003634_abnormal_glial_cell | 0.34617873 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.34388443 |
| 149 | MP0000750_abnormal_muscle_regeneration | 0.34357909 |
| 150 | MP0005391_vision/eye_phenotype | 0.33391962 |
| 151 | MP0000249_abnormal_blood_vessel | 0.33329255 |
| 152 | MP0004185_abnormal_adipocyte_glucose | 0.33067860 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.33014149 |
| 154 | MP0002060_abnormal_skin_morphology | 0.32841967 |
| 155 | MP0008873_increased_physiological_sensi | 0.32829213 |
| 156 | MP0005187_abnormal_penis_morphology | 0.32766325 |
| 157 | MP0002090_abnormal_vision | 0.28360216 |
| 158 | MP0001881_abnormal_mammary_gland | 0.27931997 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.27851659 |
| 160 | MP0003699_abnormal_female_reproductive | 0.27833067 |
| 161 | MP0002822_catalepsy | 0.27766143 |
| 162 | MP0002928_abnormal_bile_duct | 0.27358841 |
| 163 | MP0003115_abnormal_respiratory_system | 0.27297059 |
| 164 | MP0003075_altered_response_to | 0.26584066 |
| 165 | MP0006082_CNS_inflammation | 0.25596380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperaldosteronism (HP:0000859) | 9.91590691 |
| 2 | Abnormal sex determination (HP:0012244) | 7.72924956 |
| 3 | Sex reversal (HP:0012245) | 7.72924956 |
| 4 | Deep venous thrombosis (HP:0002625) | 7.70308109 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.47487535 |
| 6 | Hypoplasia of the uterus (HP:0000013) | 7.46971551 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.77688318 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70754215 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 6.48319893 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 6.23783305 |
| 11 | Xanthomatosis (HP:0000991) | 6.13168922 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.93468227 |
| 13 | Aplasia/hypoplasia of the uterus (HP:0008684) | 5.38034952 |
| 14 | Clitoromegaly (HP:0000057) | 5.22142235 |
| 15 | Hypolipoproteinemia (HP:0010981) | 5.18774791 |
| 16 | Adrenal overactivity (HP:0002717) | 5.16950204 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 5.14297874 |
| 18 | Testicular neoplasm (HP:0010788) | 4.91401792 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.71016988 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.67147946 |
| 21 | Hyperammonemia (HP:0001987) | 4.64677037 |
| 22 | Joint hemorrhage (HP:0005261) | 4.61397580 |
| 23 | Ketosis (HP:0001946) | 4.38754221 |
| 24 | Epidermoid cyst (HP:0200040) | 4.31389866 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.30899822 |
| 26 | Gonadal dysgenesis (HP:0000133) | 4.18177598 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17122175 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.17083156 |
| 29 | Hyperglycinemia (HP:0002154) | 4.16776396 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14403247 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07431362 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92305590 |
| 33 | Complement deficiency (HP:0004431) | 3.89245659 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.89138956 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.83200330 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78501008 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.78148916 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78148916 |
| 39 | Hyperglycinuria (HP:0003108) | 3.76534384 |
| 40 | Accelerated skeletal maturation (HP:0005616) | 3.68382881 |
| 41 | Hypokalemia (HP:0002900) | 3.62439084 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.47494916 |
| 43 | Fat malabsorption (HP:0002630) | 3.47361044 |
| 44 | Abnormality of the clitoris (HP:0000056) | 3.44705765 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42090443 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32999483 |
| 47 | Abnormality of the axillary hair (HP:0100134) | 3.30665251 |
| 48 | Abnormality of secondary sexual hair (HP:0009888) | 3.30665251 |
| 49 | Secondary amenorrhea (HP:0000869) | 3.26552640 |
| 50 | Hyperbilirubinemia (HP:0002904) | 3.24220376 |
| 51 | * Male pseudohermaphroditism (HP:0000037) | 3.07170060 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 3.06421081 |
| 53 | Ketoacidosis (HP:0001993) | 3.04181855 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00540078 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.92345794 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.90816282 |
| 57 | Vascular calcification (HP:0004934) | 2.89667348 |
| 58 | Abnormal spermatogenesis (HP:0008669) | 2.88565066 |
| 59 | Spontaneous abortion (HP:0005268) | 2.85961355 |
| 60 | Myocardial infarction (HP:0001658) | 2.85764658 |
| 61 | Abnormality of complement system (HP:0005339) | 2.85302525 |
| 62 | Premature ovarian failure (HP:0008209) | 2.81586492 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.78336028 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.77729048 |
| 65 | Hyperpituitarism (HP:0010514) | 2.75230127 |
| 66 | Hypospadias (HP:0000047) | 2.74335329 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.72015724 |
| 68 | Decreased testicular size (HP:0008734) | 2.70624756 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.67961988 |
| 70 | Skin nodule (HP:0200036) | 2.66241032 |
| 71 | Metabolic acidosis (HP:0001942) | 2.65603325 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.61559613 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.59991320 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59991320 |
| 75 | Abnormality of potassium homeostasis (HP:0011042) | 2.56725625 |
| 76 | Congenital sensorineural hearing impairment (HP:0008527) | 2.56115380 |
| 77 | Choanal stenosis (HP:0000452) | 2.55722748 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.52244293 |
| 79 | Spastic diplegia (HP:0001264) | 2.50422572 |
| 80 | Mitral stenosis (HP:0001718) | 2.50064802 |
| 81 | Steatorrhea (HP:0002570) | 2.49224343 |
| 82 | Lethargy (HP:0001254) | 2.45916921 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.44173627 |
| 84 | Cholecystitis (HP:0001082) | 2.44173627 |
| 85 | Male infertility (HP:0003251) | 2.38153252 |
| 86 | Malnutrition (HP:0004395) | 2.37912488 |
| 87 | Large earlobe (HP:0009748) | 2.36921814 |
| 88 | Mesangial abnormality (HP:0001966) | 2.36573577 |
| 89 | Acanthocytosis (HP:0001927) | 2.34511746 |
| 90 | Cerebral edema (HP:0002181) | 2.34382070 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.34360635 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34360635 |
| 93 | Amyloidosis (HP:0011034) | 2.33529828 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.33375485 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.32894680 |
| 96 | Irritability (HP:0000737) | 2.32502235 |
| 97 | Glomerulonephritis (HP:0000099) | 2.30313506 |
| 98 | Bicornuate uterus (HP:0000813) | 2.29153628 |
| 99 | Brushfield spots (HP:0001088) | 2.28557360 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.27086884 |
| 101 | Cholelithiasis (HP:0001081) | 2.26391068 |
| 102 | Aplasia of the musculature (HP:0100854) | 2.26351653 |
| 103 | Precocious puberty (HP:0000826) | 2.25406753 |
| 104 | Atrioventricular block (HP:0001678) | 2.21047826 |
| 105 | Hemorrhage of the eye (HP:0011885) | 2.20060456 |
| 106 | Bifid tongue (HP:0010297) | 2.19369592 |
| 107 | Tracheal stenosis (HP:0002777) | 2.18944034 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16714971 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16714971 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16714971 |
| 111 | Esophageal varix (HP:0002040) | 2.13015704 |
| 112 | Menorrhagia (HP:0000132) | 2.11486645 |
| 113 | Neonatal onset (HP:0003623) | 2.08133339 |
| 114 | Absent eyebrow (HP:0002223) | 2.07859417 |
| 115 | Nausea (HP:0002018) | 2.06980822 |
| 116 | Late onset (HP:0003584) | 2.06900210 |
| 117 | Gout (HP:0001997) | 2.05904345 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 2.05634502 |
| 119 | Vomiting (HP:0002013) | 2.04604315 |
| 120 | Female pseudohermaphroditism (HP:0010458) | 2.04526042 |
| 121 | Enlarged kidneys (HP:0000105) | 2.03173216 |
| 122 | Thrombophlebitis (HP:0004418) | 2.02259642 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 2.00259496 |
| 124 | Renal salt wasting (HP:0000127) | 13.7790898 |
| 125 | Decreased circulating renin level (HP:0003351) | 11.0155728 |
| 126 | Enlarged penis (HP:0000040) | 10.2738717 |
| 127 | Metaphyseal dysplasia (HP:0100255) | 1.97588952 |
| 128 | Bilateral microphthalmos (HP:0007633) | 1.97110179 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.96742691 |
| 130 | Morphological abnormality of the middle ear (HP:0008609) | 1.96338690 |
| 131 | Pancreatitis (HP:0001733) | 1.95159665 |
| 132 | Prolonged QT interval (HP:0001657) | 1.94313134 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94021379 |
| 134 | Azoospermia (HP:0000027) | 1.91819758 |
| 135 | Generalized aminoaciduria (HP:0002909) | 1.89830107 |
| 136 | Gingival bleeding (HP:0000225) | 1.89156192 |
| 137 | Infertility (HP:0000789) | 1.87432386 |
| 138 | Abnormal pancreas size (HP:0012094) | 1.86720489 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 1.86551426 |
| 140 | Nephritis (HP:0000123) | 1.86478458 |
| 141 | Poikilocytosis (HP:0004447) | 1.84518125 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.81456729 |
| 143 | Stroke (HP:0001297) | 1.81414238 |
| 144 | Reticulocytosis (HP:0001923) | 1.81078656 |
| 145 | Abnormality of the Achilles tendon (HP:0005109) | 1.80725117 |
| 146 | Syncope (HP:0001279) | 1.80318799 |
| 147 | Hydroxyprolinuria (HP:0003080) | 1.79926522 |
| 148 | Abnormality of proline metabolism (HP:0010907) | 1.79926522 |
| 149 | Abnormality of the lower motor neuron (HP:0002366) | 1.79338461 |
| 150 | Renal cortical cysts (HP:0000803) | 1.77375108 |
| 151 | Status epilepticus (HP:0002133) | 1.75777496 |
| 152 | Acne (HP:0001061) | 1.74845711 |
| 153 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.74590824 |
| 154 | Upper motor neuron abnormality (HP:0002127) | 1.74552967 |
| 155 | Sensorimotor neuropathy (HP:0007141) | 1.74092447 |
| 156 | Cervical subluxation (HP:0003308) | 1.73299690 |
| 157 | Gonadotropin excess (HP:0000837) | 1.72008251 |
| 158 | * Gynecomastia (HP:0000771) | 1.66901625 |
| 159 | Midline defect of the nose (HP:0004122) | 1.62401996 |
| 160 | Cerebral palsy (HP:0100021) | 1.59807556 |
| 161 | Breast hypoplasia (HP:0003187) | 1.57279137 |
| 162 | Sparse lateral eyebrow (HP:0005338) | 1.56883557 |
| 163 | Absent hair (HP:0002298) | 1.53733416 |
| 164 | Short humerus (HP:0005792) | 1.52402027 |
| 165 | Cutaneous finger syndactyly (HP:0010554) | 1.51706404 |
| 166 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.51356997 |
| 167 | Osteolytic defects of the hand bones (HP:0009699) | 1.51356997 |
| 168 | Myelomeningocele (HP:0002475) | 1.51141449 |
| 169 | Hypoplastic nipples (HP:0002557) | 1.50818130 |
| 170 | Neonatal hypoglycemia (HP:0001998) | 1.48706888 |
| 171 | Abnormality of carpal bone ossification (HP:0006257) | 1.48281412 |
| 172 | Hip contracture (HP:0003273) | 1.46788467 |
| 173 | Visceral angiomatosis (HP:0100761) | 1.46203806 |
| 174 | Absent hand (HP:0004050) | 1.46057405 |
| 175 | Limited hip movement (HP:0008800) | 1.45531278 |
| 176 | Absent eyelashes (HP:0000561) | 1.45099354 |
| 177 | Ovarian neoplasm (HP:0100615) | 1.41268139 |
| 178 | Persistence of primary teeth (HP:0006335) | 1.39971803 |
| 179 | Thoracolumbar scoliosis (HP:0002944) | 1.38103392 |
| 180 | Abnormality of the aortic arch (HP:0012303) | 1.38084252 |
| 181 | Cupped ear (HP:0000378) | 1.37675253 |
| 182 | Wrist flexion contracture (HP:0001239) | 1.37452809 |
| 183 | Hemangiomatosis (HP:0007461) | 1.36368135 |
| 184 | Scrotal hypoplasia (HP:0000046) | 1.36366508 |
| 185 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.35360665 |
| 186 | Abnormality of the pubic bones (HP:0003172) | 1.35076606 |
| 187 | Breech presentation (HP:0001623) | 1.34594240 |
| 188 | Abnormal EKG (HP:0003115) | 1.34401599 |
| 189 | Primary adrenal insufficiency (HP:0008207) | 1.34340621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.63191163 |
| 2 | SIK1 | 4.24433949 |
| 3 | DDR2 | 3.70011354 |
| 4 | FGFR4 | 3.66856230 |
| 5 | ERN1 | 3.54538708 |
| 6 | PDK4 | 3.46430175 |
| 7 | PDK3 | 3.46430175 |
| 8 | TRIB3 | 3.34123445 |
| 9 | PKN2 | 3.09116951 |
| 10 | MELK | 3.04578660 |
| 11 | MAP3K5 | 2.37589902 |
| 12 | ICK | 2.18980552 |
| 13 | INSRR | 2.18514965 |
| 14 | LATS1 | 2.14288505 |
| 15 | AKT3 | 11.6411617 |
| 16 | MAP2K4 | 1.97242508 |
| 17 | PDK2 | 1.95730321 |
| 18 | DAPK2 | 1.89229781 |
| 19 | PTK6 | 1.85370280 |
| 20 | TAOK3 | 1.81198828 |
| 21 | AKT2 | 1.76543359 |
| 22 | FLT3 | 1.73042375 |
| 23 | PIK3CG | 1.65265372 |
| 24 | MST1R | 1.64859713 |
| 25 | MAP3K10 | 1.40891683 |
| 26 | FGFR2 | 1.37872679 |
| 27 | RIPK1 | 1.30848838 |
| 28 | ERBB4 | 1.24804628 |
| 29 | PDGFRA | 1.22009135 |
| 30 | TYK2 | 1.21717420 |
| 31 | PIM1 | 1.20864663 |
| 32 | GRK5 | 1.16539973 |
| 33 | CAMK1D | 1.15669164 |
| 34 | SCYL2 | 1.14687255 |
| 35 | ABL2 | 1.08694491 |
| 36 | MAPK11 | 1.08406330 |
| 37 | EEF2K | 1.08397279 |
| 38 | DYRK1B | 1.08209451 |
| 39 | NTRK1 | 1.06079447 |
| 40 | KDR | 1.04125091 |
| 41 | TRPM7 | 0.98707590 |
| 42 | STK38L | 0.96044394 |
| 43 | MAP2K6 | 0.94418110 |
| 44 | TESK1 | 0.93569507 |
| 45 | MAP3K3 | 0.91902549 |
| 46 | FRK | 0.90318429 |
| 47 | PRKAA2 | 0.88689920 |
| 48 | NLK | 0.88111519 |
| 49 | MAP3K7 | 0.87163311 |
| 50 | JAK2 | 0.87089734 |
| 51 | SGK1 | 0.87011501 |
| 52 | PRKD3 | 0.86922536 |
| 53 | CAMK1G | 0.86342957 |
| 54 | PINK1 | 0.84484443 |
| 55 | MAPK4 | 0.83932313 |
| 56 | TYRO3 | 0.82849759 |
| 57 | CDK6 | 0.82671150 |
| 58 | PTK2B | 0.82649899 |
| 59 | EPHB2 | 0.81966820 |
| 60 | PRKCZ | 0.81028931 |
| 61 | MET | 0.77224741 |
| 62 | PRKACG | 0.76641224 |
| 63 | MAPK12 | 0.76073353 |
| 64 | YES1 | 0.73605333 |
| 65 | PDK1 | 0.72764762 |
| 66 | WNK3 | 0.72635880 |
| 67 | CDK4 | 0.72606688 |
| 68 | PDPK1 | 0.70464299 |
| 69 | STK10 | 0.70157336 |
| 70 | CSK | 0.70146479 |
| 71 | NEK9 | 0.68815730 |
| 72 | MAPK3 | 0.68440041 |
| 73 | MTOR | 0.67828051 |
| 74 | MAP2K3 | 0.66981496 |
| 75 | ERBB2 | 0.66337376 |
| 76 | TBK1 | 0.65880703 |
| 77 | LATS2 | 0.64216491 |
| 78 | TGFBR2 | 0.61707572 |
| 79 | GSK3A | 0.61349755 |
| 80 | PTK2 | 0.60704392 |
| 81 | EPHB1 | 0.59387166 |
| 82 | CSNK1A1L | 0.58356885 |
| 83 | STK3 | 0.57137560 |
| 84 | EPHA3 | 0.57028341 |
| 85 | GRK6 | 0.54305854 |
| 86 | RET | 0.54126195 |
| 87 | STK38 | 0.51711446 |
| 88 | WNK4 | 0.51693258 |
| 89 | PHKG1 | 0.50617579 |
| 90 | PHKG2 | 0.50617579 |
| 91 | ACVR1B | 0.50325937 |
| 92 | MAPKAPK5 | 0.49422060 |
| 93 | PRKAA1 | 0.48210598 |
| 94 | TIE1 | 0.47532827 |
| 95 | JAK1 | 0.47097443 |
| 96 | FER | 0.46089446 |
| 97 | MAPK15 | 0.44971423 |
| 98 | MAP3K2 | 0.44517145 |
| 99 | PAK2 | 0.44092616 |
| 100 | SGK2 | 0.43750809 |
| 101 | MAPK7 | 0.43701654 |
| 102 | CSNK1G2 | 0.42658591 |
| 103 | EPHA4 | 0.39966028 |
| 104 | ADRBK1 | 0.38903732 |
| 105 | PRKCG | 0.37273149 |
| 106 | IGF1R | 0.36591312 |
| 107 | MAP2K1 | 0.36578416 |
| 108 | MAP3K12 | 0.35438151 |
| 109 | PRKCQ | 0.34939973 |
| 110 | CSNK1G1 | 0.34337529 |
| 111 | CAMK2G | 0.33877257 |
| 112 | CSF1R | 0.33053942 |
| 113 | FGFR3 | 0.32996188 |
| 114 | OBSCN | 0.31735029 |
| 115 | SGK3 | 0.31441968 |
| 116 | MAP3K11 | 0.31396396 |
| 117 | PAK3 | 0.31182473 |
| 118 | CAMK4 | 0.30015342 |
| 119 | BMPR1B | 0.30001229 |
| 120 | * PRKACA | 0.29500485 |
| 121 | SGK223 | 0.28267657 |
| 122 | SGK494 | 0.28267657 |
| 123 | MYLK | 0.28106444 |
| 124 | ROCK2 | 0.27894752 |
| 125 | MAP4K2 | 0.27099351 |
| 126 | STK39 | 0.26717206 |
| 127 | TTN | 0.25859018 |
| 128 | LRRK2 | 0.24970472 |
| 129 | CAMKK1 | 0.24816182 |
| 130 | MAP3K14 | 0.24749140 |
| 131 | FGFR1 | 0.24427491 |
| 132 | MAPK1 | 0.24260486 |
| 133 | NTRK3 | 0.24222869 |
| 134 | MAP3K6 | 0.24135629 |
| 135 | PDGFRB | 0.23787915 |
| 136 | CAMKK2 | 0.23331538 |
| 137 | CDK7 | 0.22919908 |
| 138 | RPS6KB1 | 0.22860529 |
| 139 | MAP3K4 | 0.22815542 |
| 140 | CAMK1 | 0.22678161 |
| 141 | MAPKAPK3 | 0.22588762 |
| 142 | PRKACB | 0.22237090 |
| 143 | EGFR | 0.22016685 |
| 144 | RPS6KA3 | 0.21674735 |
| 145 | MAP2K2 | 0.21552602 |
| 146 | CDC42BPA | 0.20530663 |
| 147 | ROCK1 | 0.20185727 |
| 148 | CSNK1G3 | 0.20160108 |
| 149 | OXSR1 | 0.19694862 |
| 150 | MUSK | 0.19247864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 5.79120237 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.89463613 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.48419294 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.47149277 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29951797 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27555485 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92558368 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61493540 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49727351 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.49054507 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39060465 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37510091 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.32675709 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32128328 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31558584 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23595532 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.22067603 |
| 18 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.17990804 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.15347867 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.14826859 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08082081 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06847139 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.96071054 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93808107 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.83272901 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75092323 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72804693 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67945095 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66375448 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65131946 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63089056 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61091881 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58542385 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54419682 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54095409 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.50220082 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44241052 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42060318 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41883855 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41491786 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34696006 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32127841 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30268781 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26317398 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25403436 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19943645 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18893690 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.10233649 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01697598 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00092087 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97701960 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96928193 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95440993 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93750921 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93389395 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93286375 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93266720 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85105696 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83452515 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83383635 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82389338 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74526052 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73966725 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73698412 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68580241 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67812705 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.63690696 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60759478 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55801059 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51324709 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50407901 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47898336 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.47503243 |
| 74 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45316101 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44100570 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43624987 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43459551 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43210266 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42378551 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.41330888 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36428710 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35192595 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35073408 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34562096 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34444855 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31775303 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31624470 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31378604 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28285375 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27683298 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27674039 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27575253 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26455239 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26447485 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26176266 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.25856177 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.23432351 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.23170976 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21502278 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19571429 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18641554 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18634172 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17490072 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.14891748 |
| 105 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14640499 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.13549258 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.13470628 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.13223813 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12106500 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.11860082 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.11735926 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.11195966 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10037777 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08804415 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.06499275 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06316257 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.06300403 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05914918 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2691673 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2593146 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2468934 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | -0.2375436 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2300900 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2258958 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2097595 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1935160 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1821977 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1771239 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1656017 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1528401 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1418738 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1318855 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1166689 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1090543 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0992138 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0960310 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0937720 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0876814 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | -0.0119123 |

